RxDoctor Payments Data

Caitlyn Kay

Family · Toms River, NJNPI 1629833835

Payments from drug & device makers

$2,986in general payments, 2019–2025

Across 139 payments — averaging $21.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$628
  • Novo Nordisk$509
  • Amneal Pharmaceuticals LLC$265
  • Medtronic$238
  • Tandem Diabetes Care, Inc.$213
  • AbbVie$169
  • plus $964 from 15 others

What the payments were for

  • Food & beverage$2,986100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,986 in reported general payments places this provider in the 90th percentile of 2,692 family providers in New Jersey.

See all family providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide55$86,787
MounjaroTirzepatide22$26,070
JardianceEmpagliflozin17$22,224
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog18$9,181
Fiasp FlextouchInsulin Aspart (Niacinamide)13$8,687
Nano 2nd Gen Pen NeedlePen Needle, Diabetic58$7,979
Novolog FlexpenInsulin Aspart18$5,589
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$4,864
Humalog Kwikpen U-100Insulin Lispro11$3,688
SynthroidLevothyroxine Sodium16$1,506
Levothyroxine Sodium25$323
Glipizide15$310
Methimazole12$175
Metformin Hcl20$52

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$509$86,78755 claims
Lilly USA, LLCMounjaro$628$26,07022 claims
Boehringer IngelheimJardiance$104$22,22417 claims
AbbVieSynthroid$169$1,50616 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$265$32325 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,692 family providers in New Jersey.

Other family in Toms River

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →